Phathom Pharmaceuticals PHAT

Phathom Pharmaceuticals, Inc. · Nasdaq · Pharmaceutical Preparations

$6.28+4.84%close on Oct. 28, 2026 · volume 2.1M · Yahoo Finance

Price, last 47 sessions

$6.00$7.00$8.00$9.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $9.57 · low $5.74 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 8 →
  • 8-KOct. 26, 2026, 6:02 a.m. ETView on SEC.gov

    Other events

    AI summary, unreviewedPhathom Pharmaceuticals Discloses FDA Public Docket on VOQUEZNA NCE Exclusivity Challenge by BDR, Comments Due November 23, 2026

  • 8-KOct. 23, 2026, 5 p.m. ETView on SEC.gov

    Other events

    AI summary, unreviewedPhathom Pharmaceuticals Faces BDR Lawsuit Challenging VOQUEZNA GAIN Act NCE Exclusivity Through May 3, 2032

  • 4Oct. 8, 2026, 5:44 p.m. ETView on SEC.gov
  • 8-KSept. 29, 2026, 4:45 p.m. ETView on SEC.gov

    Other events

  • 4Sept. 8, 2026, 4:30 p.m. ETView on SEC.gov
  • 10-QJuly 30, 2026, 7:05 a.m. ETView on SEC.gov
  • 8-KJuly 30, 2026, 7:05 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

  • SCHEDULE 13GJuly 29, 2026, 3:19 p.m. ETView on SEC.gov